Cite
HARVARD Citation
Zweifel, M. et al. (2017). Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients. Endocrine connections. 6 (7), pp. 549-556. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zweifel, M. et al. (2017). Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients. Endocrine connections. 6 (7), pp. 549-556. [Online].